Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
442.96
-3.87 (-0.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,149,410
Open
443.17
Bid (Size)
441.65 (40)
Ask (Size)
443.90 (80)
Prev. Close
446.83
Today's Range
441.72 - 448.69
52wk Range
362.50 - 507.92
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?
↗
June 08, 2026
A clinical-stage innovator faces off against an established biotech powerhouse, each with distinct financials and risk profiles shaping their 2026 outlook.
Via
The Motley Fool
CRISPR Therapeutics Has $2.4 Billion in Cash and an Approved Drug. Why Is Its Stock Trading Nearly 40% Below the Wall Street Consensus?
↗
June 08, 2026
The company seems to be doing everything it's supposed to be doing; the stock just isn't responding.
Via
The Motley Fool
Performance
YTD
-2.0%
-2.0%
1 Month
+1.8%
+1.8%
3 Month
-3.9%
-3.9%
6 Month
+0.2%
+0.2%
1 Year
-0.7%
-0.7%
More News
Read More
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference
June 05, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX): Affordable Growth with Strong Fundamentals
↗
June 01, 2026
Via
Chartmill
Vertex Pharmaceuticals (NASDAQ:VRTX): Strong Growth Meets a Technical Setup for a Potential Breakout
↗
May 28, 2026
Via
Chartmill
The Best Stocks to Invest $500 in Right Now
↗
June 04, 2026
Via
The Motley Fool
Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10
June 03, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy
June 01, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Fits the Affordable Growth Profile With Strong Earnings and Reasonable Valuation
↗
May 05, 2026
Via
Chartmill
Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q1 Estimates as New Drug Launches Drive Diversification
↗
May 04, 2026
Via
Chartmill
2 Healthcare Stocks with Exciting Potential and 1 Facing Challenges
May 29, 2026
Via
StockStory
Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?
↗
May 25, 2026
Via
The Motley Fool
Which S&P500 stocks are moving on Tuesday?
↗
May 12, 2026
Via
Chartmill
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?
↗
May 11, 2026
Via
The Motley Fool
Vertex to Participate in Upcoming May Investor Conferences
May 11, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
5 Must-Read Analyst Questions From Vertex Pharmaceuticals’s Q1 Earnings Call
May 11, 2026
Via
StockStory
Topics
Earnings
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany
May 06, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Is This Millionaire-Maker Biotech Stock a Buy Right Now?
↗
May 06, 2026
Via
The Motley Fool
Topics
Initial Public Offering
Vertex (VRTX) Q1 2026 Earnings Call Transcript
↗
May 04, 2026
Via
The Motley Fool
Topics
Earnings
Vertex Pharmaceuticals Reports Mixed Q1 Results
↗
May 04, 2026
Via
Benzinga
Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q1 CY2026 Sales Expectations
May 04, 2026
Via
StockStory
Vertex Reports First Quarter 2026 Financial Results
May 04, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex (VRTX) Q2 2025 Earnings Call Transcript
↗
May 04, 2026
Via
The Motley Fool
Topics
Earnings
Vertex Pharmaceuticals (VRTX) Q1 Earnings: What To Expect
May 02, 2026
Via
StockStory
Got $1,000? Which of These Beaten-Down Healthcare Stocks Is Worth Buying?
↗
May 02, 2026
Via
The Motley Fool
Topics
World Trade
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 442.96
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 06/08/26 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 114.92B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 115B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.